The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.817%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 36.00
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notifiable interest in securities

3 Apr 2009 13:24

RNS Number : 1163Q
China Real Estate Opportunities PLC
03 April 2009
 



3 April 2009

China Real Estate Opportunities plc 

Notifiable interest in securities 

The Board of China Real Estate Opportunities plc ("CREO" or the "Company") announces that on 2 April 2009, the Company was notified by Treasury Holdings (which is owned as to 50 per cent. by Richard Barrett, a director and significant shareholder of the Company, and as to 50 per cent. by John Ronan, a significant shareholder of the Company) that the following transactions have been undertaken in the ordinary shares of the Company. 

Treasury Holdings has disposed of 661,000 ordinary shares to Treasury Properties Limited. 

Treasury Holdings has disposed of 2,000,000 ordinary shares to Jasbay Properties Limited.

420,653 ordinary shares held by Treasury Holdings in trust for Treasury Holdings China Limited have been transferred to Treasury Holdings China Limited.

Treasury Holdings China Limited has disposed of 420,653 ordinary shares to Treasury Properties Limited.

In addition the Company was notified on 2 April 2009 by Real Estate Opportunities Limited that they have disposed of 8,387,941 ordinary shares, in equal amounts, to four wholly owned subsidiaries being Real Estate Opportunities Holdings Limited, REO (CREO Holdings) No.1 Limited, REO (CREO Holdings) No.2 Limited and REO (CREO Holdings) No.3 Limited. 

All the above transactions were undertaken at a price of £2.175 per ordinary share.

There is no change in the ultimate beneficial ownership of these ordinary shares. The Concert Party (as defined in the Notice of Extraordinary General Meeting) remain interested in 25,973,984 ordinary shares, representing 54.96 per cent of the Company's issued share capital. 

Contact: 

CREO 

Ray Horney, Chairman 

Tel: + 44 (0) 1273 775 225 

 

Sarah Moriarty, Investor Relations 

Tel: + 353 1 618 9455 

Matrix Corporate Capital LLP 

Paul Fincham, Rob Naylor 

Tel: + 44 (0) 20 3206 7000 

Davy 

Des Carville 

Tel: + 353 1 679 6363 

Bankside Consultants 

Simon Rothschild, Oliver Winters 

Tel: + 44 (0) 20 7367 8888 

Murray Consultants 

Ed Micheau 

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOUURKURSRAR
Date   Source Headline
31st Dec 20217:00 amRNSTotal Voting Rights
23rd Dec 20217:00 amRNSExercise of Options
30th Nov 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSExercise of Options
12th Nov 20217:00 amRNSAcquisition of Aber Electronics Limited
11th Nov 20217:00 amRNSAppointment of Joint Broker
30th Sep 202112:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSHalf-year Report
9th Sep 202111:23 amRNSDirector/PDMR Shareholding
8th Sep 20213:59 pmRNSHolding(s) in Company
16th Aug 20213:34 pmRNSOpen Offer Launch, Posting of Circular & GM Notice
13th Aug 20214:45 pmRNSResult of Placing
12th Aug 20215:37 pmRNSProposed Placing & Open Offer, Launch of ABB
30th Jul 20215:00 pmRNSTotal Voting Rights
20th Jul 20213:42 pmRNSShare Awards, Director Dealings & Issue of Equity
16th Jul 20217:00 amRNSOpening of United States East Coast Headquarters
1st Jul 20218:00 amRNSIssue of Equity
30th Jun 202110:30 amRNSResult of AGM
16th Jun 20217:00 amRNSMicroBlate Fine’s first in-human use update
14th Jun 20217:00 amRNSAcquisition of freehold site for £4.25m
4th Jun 20217:01 amRNSNotice of AGM
4th Jun 20217:00 amRNSFinal Results
26th May 20217:00 amRNSFurther health economics data validates technology
19th May 20217:00 amRNSTrading Update
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSExercise of Options
19th Feb 202111:31 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSTrading update
7th Jan 20217:00 amRNSUS FDA clearance for MicroBlate™ Flex device
9th Dec 202011:06 amRNSSecond Price Monitoring Extn
9th Dec 202011:00 amRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSFirst clinical use of new Creo GI product
24th Nov 20201:36 pmRNSExercise of Options
3rd Nov 20207:00 amRNSAcquisition of Boucart Medical SRL
2nd Nov 20207:00 amRNSUS FDA clearance for MicroBlate™ Fine device
23rd Sep 20207:00 amRNSHalf-year Report
26th Aug 20204:09 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSExercise of Options
3rd Aug 20207:00 amRNSVideo abstract published endorsing Speedboat
24th Jul 202011:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSAcquisition of Albyn Medical S.L.
13th Jul 202010:37 amRNSSecretary of State for Wales site visit
13th Jul 202010:08 amRNSSecretary of State for Wales site visit
6th Jul 20207:00 amRNSDirectorate Change
2nd Jul 20207:00 amRNSDevelopment loan for plasma sterilising product
24th Jun 202010:30 amRNSResult of AGM
15th Jun 20207:00 amRNSCE mark for five new devices
8th Jun 20207:00 amRNSIET Prize nomination
3rd Jun 20207:00 amRNSPositive NHS health economics data
27th May 20207:00 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.